Welcome to our dedicated page for Cronos Group news (Ticker: CRON), a resource for investors and traders seeking the latest updates and insights on Cronos Group stock.
Cronos Group Inc. (CRON) is a global leader in cannabis innovation, operating across medicinal and recreational markets with brands like Peace Naturals and Spinach. This page provides investors and industry observers with centralized access to official press releases, financial updates, and strategic developments.
Track CRON's progress through earnings reports, regulatory milestones, product launches, and partnership announcements. Our curated news collection ensures you stay informed about operational expansions, research breakthroughs, and market positioning in the evolving cannabis sector.
All content is sourced from verified channels to maintain accuracy and compliance with financial disclosure standards. Bookmark this page for efficient monitoring of CRON's performance across North American, European, and Australian markets.
Cronos Group reported a significant 80% increase in consolidated net revenue for Q3 2021, totaling $20.4 million, driven by growth in Canada and the Israeli market. The company announced strategic realignment to enhance business efficiency and focus on innovation. However, it also recorded an impairment charge of $236.1 million affecting goodwill and long-lived assets. Despite the positive revenue growth, adjusted EBITDA worsened to $(46.8) million, indicating ongoing financial challenges. The company is committed to improving internal controls and expanding its product portfolio.
Cronos Group Inc. (NASDAQ: CRON) will host its 2021 Third Quarter Earnings Conference Call on February 18, 2022, at 8:30 a.m. EST. The call will cover the company’s financial results and include a Q&A session. A live audio webcast will be accessible on the company's website, and an archived version will also be available. Cronos Group, a leading cannabinoid company, focuses on building a disruptive intellectual property portfolio and an iconic brand lineup that includes PEACE NATURALS®, COVE™, Spinach®, Lord Jones®, Happy Dance®, and PEACE+™.
Cronos Group (NASDAQ: CRON) has issued a default status report as per NP 12-203 guidelines, following the announcement of a management cease trade order (MCTO) on November 9, 2021. The MCTO restricts trading by the CEO and CFO until the filing of the overdue Quarterly Report on Form 10-Q for Q3 2021, expected by February 18, 2022. However, the company confirms no material changes have occurred since the original announcement. Cronos Group remains committed to adhering to NP 12-203 guidelines while in default.
Cronos Group Inc. (NASDAQ: CRON) issued a default status report in compliance with NP 12-203, acknowledging a management cease trade order (MCTO) due to delays in filing its Quarterly Report for Q3 2021. Initially announced on November 9, 2021, the company has until February 18, 2022, to meet filing deadlines. The MCTO restricts trading for the CEO and CFO but not other shareholders. Cronos assures that no new material issues have arisen since the original announcement and commits to continue adhering to NP 12-203 guidelines until compliance is achieved.
Cronos Group (NASDAQ: CRON) has issued a default status report following its application for a management cease trade order (MCTO) due to an inability to file its Quarterly Report on Form 10-Q for the period ending September 30, 2021, by the deadline. The MCTO, effective November 16, 2021, restricts trading by executives until necessary filings are made. Cronos anticipates filing by January 31, 2022, and reports no new material developments since the original announcement. The company is committed to compliance with alternative information guidelines while in default.
Cronos Group Inc. (NASDAQ: CRON) provides a default status report in compliance with NP 12-203 due to a management cease trade order (MCTO) stemming from its inability to file the Quarterly Report on Form 10-Q for Q3 2021 on time. The MCTO, issued on November 16, 2021, restricts trading by the CEO and CFO until the Required Filings are completed. The company aims to submit these filings by January 31, 2022, though this is not guaranteed. Cronos confirms no other significant changes since its initial announcement and will continue to comply with NP 12-203 guidelines.
Cronos Group Inc. (NASDAQ: CRON) has issued a default status report under NP 12-203 due to its inability to file the Quarterly Report on Form 10-Q for the period ending September 30, 2021, by the deadline. Following the announcement on November 9, 2021, a management cease trade order (MCTO) was issued on November 16, 2021, restricting trades by the CEO and CFO. The company is working to meet the filing deadline, now expected by January 31, 2022, and confirms that there have been no material changes since the original announcement.
NatuEra has launched the Holiday Chill Bundle, a collection of five CBD wellness products aimed at alleviating holiday stress. The bundle features tinctures, capsules, and gummies, all containing Lemon Balm and varying levels of CBD sourced from sustainably grown hemp in Colombia's Andes Mountains. Priced at $99.99, the bundle offers a 23% discount compared to individual purchases and includes free shipping. NatuEra's products are manufactured in GMP-certified facilities, ensuring high quality and compliance with U.S. standards.
Aurora Cannabis (ACB) and 22nd Century Group (XXII) announced a licensing agreement with Cronos Group (CRON) to advance cannabinoid biosynthesis research. This non-exclusive deal aims to enhance the production of rare cannabinoids such as CBG, CBC, and CBN efficiently and with high purity. According to CEO Miguel Martin, the collaboration is a significant step towards commercializing cannabinoid products, which could benefit health and wellness applications. Aurora and 22nd Century also plan to enforce their intellectual property rights against infringements.
Cronos Group (NASDAQ: CRON) reports on its management cease trade order (MCTO) issued on November 16, 2021, due to the inability to file the Quarterly Report on Form 10-Q for the period ending September 30, 2021. The MCTO restricts trading for executive officers until the required filings are made. The company confirms no material changes since the original announcement and is committed to fulfilling alternative information guidelines. Cronos continues to work toward completing the necessary filings and emphasizes forward-looking statements about potential risks and uncertainties.
FAQ
What is the current stock price of Cronos Group (CRON)?
What is the market cap of Cronos Group (CRON)?
